首页> 外文OA文献 >Histological course of nonalcoholic fatty liver disease in Japanese patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis
【2h】

Histological course of nonalcoholic fatty liver disease in Japanese patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis

机译:Histological course of nonalcoholic fatty liver disease in Japanese patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE - The goal of this study was to examine whether metabolic abnormalities are responsible for the histological changes observed in Japanese patients with nonalcoholic fatty liver disease (NAFLD) who have undergone serial liver biopsies. RESEARCH DESIGN AND METHODS - In total, 39 patients had undergone consecutive liver biopsies. Changes in their clinical data were analyzed, and biopsy specimens were scored histologically for stage. RESULTS - The median follow-up time was 2.4 years (range 1.0-8.5). Liver fibrosis had improved in 12 patients (30.7%), progressed in 11 patients (28.2%), and remained unchanged in 16 patients (41%). In a Cox proportional hazard model, decrease in A1C and use of insulin were associated with improvement of liver fibrosis independent of age, sex, and BMI. However, ΔA1C was more strongly associated with the improvement of liver fibrosis than use of insulin after adjustment for each other (χ2; 7.97 vs. 4.58, respectively). CONCLUSIONS - Tight glycemic control may prevent histological progression in Japanese patients with NAFLD. © 2010 by the American Diabetes Association.
机译:目的-这项研究的目的是检查代谢异常是否与日本人进行了连续肝活检的非酒精性脂肪肝疾病(NAFLD)患者的组织学变化有关。研究设计和方法-总共39例患者接受了连续的肝活检。分析其临床数据的变化,并对组织活检标本进行组织学评分。结果-中位随访时间为2.4年(范围1.0-8.5)。肝纤维化改善了12例(30.7%),进展为11例(28.2%),而16例(41%)则保持不变。在Cox比例风险模型中,A1C的减少和胰岛素的使用与年龄,性别和BMI无关的肝纤维化改善相关。但是,与彼此调整后使用胰岛素相比,ΔA1C与改善肝纤维化的关系更密切(分别为χ2; 7.97 vs. 4.58)。结论-严格的血糖控制可能会阻止日本NAFLD患者的组织学进展。 ©2010,美国糖尿病协会。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号